Page 1 of Clinical Trials for Overactive Bladder Syndrome, 55 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
Last Updated: February 9, 2009
Condition(s): Overactive Bladder Syndrome; Voiding Dysfunction
2
Completed
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
Last Updated: November 21, 2008
Condition(s): Overactive Bladder Syndrome
3
Completed
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Last Updated: November 21, 2008
Condition(s): Overactive Bladder Syndrome
4
Completed
SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
Last Updated: April 15, 2009
Condition(s): Overactive Bladder Syndrome (OABS)
5
Recruiting
The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
Last Updated: June 15, 2010
Condition(s): Overactive Bladder Syndrome
6
Completed
A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome
Last Updated: April 29, 2008
Condition(s): Overactive Bladder Syndrome
7
Active, not recruiting
Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase
Last Updated: December 15, 2008
Condition(s): Lower Urinary Tract Symptoms; Overactive Bladder Syndrome
8
Recruiting
Therapy of the Overactive Bladder Syndrome
Last Updated: December 19, 2011
Condition(s): Overactive Bladder
9
Completed
Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome
Last Updated: January 3, 2012
Condition(s): Antimuscarinic Drug
10
Completed
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
Last Updated: April 9, 2008
Condition(s): Overactive Bladder
11
Completed
Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females
Last Updated: June 23, 2010
Condition(s): Overactive Bladder Syndrome
12
Completed
Validation of a Real-Time Urodynamic Measure of Urinary Urgency
Last Updated: May 27, 2009
Condition(s): Overactive Bladder Syndrome
13
Recruiting
Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome
Last Updated: August 5, 2011
Condition(s): Overactive Bladder
14
Withdrawn
Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Treatment of Incontinence
Last Updated: February 23, 2012
Condition(s): Urinary Incontinence
15
Enrolling by invitation
Overactive Bladder (OAB) Drink Advice Study
Last Updated: September 22, 2009
Condition(s): Overactive Bladder Syndrome
16
Completed
Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder Syndrome and Detrusor Overactivity
Last Updated: March 21, 2012
Condition(s): Overactive Bladder
17
Completed
A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.
Last Updated: November 8, 2011
Condition(s): Urinary Bladder, Overactive
18
Recruiting
Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.
Last Updated: September 18, 2011
Condition(s): Lower Urinary Tract Symptoms
19
Completed
Basic Sensations Coming From the Bladder
Last Updated: April 30, 2010
Condition(s): Healthy; Overactive Bladder Syndrome
20
Recruiting
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction
Last Updated: November 29, 2011
Condition(s): Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Cystitis, Interstitial

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Overactive+Bladder+Syndrome

Page 1 of Clinical Trials for Overactive Bladder Syndrome, 55 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About